Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Roberts

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Antiviral Therapy|April 6, 2013
Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final resultsStefan Zeuzem, Tarik Asselah, Peter Angus, et al.
Journal of Hepatology|July 30, 2010
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsEric J Gowans, Stuart Roberts, Kathryn Jones, et al.
The New England Journal of Medicine|June 24, 2011
Telaprevir for retreatment of HCV infectionStefan Zeuzem, Pietro Andreone, Stanislas Pol, et al.
Hepatology International|August 25, 2022
Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort studyKurvi Patwala, David Stephen Prince, Yael Celermajer, et al.
Journal of Viral Hepatitis|May 18, 2026
Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry StudyYusuf Yilmaz, Ming-Lung Yu, Khalid Alswat, et al.
Scientific Reports|November 7, 2022
A large-scale dataset reveals taxonomic and functional specificities of wild bee communities in urban habitats of Western EuropeArthur Fauviau, Mathilde Baude, Nicolas Bazin, et al.
Hepatology International|March 3, 2026
Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statementEric Kalo, Jacinta Holmes, Purnima Bhat, et al.
Nature Ecology & Evolution|December 10, 2025
Pesticides and habitat loss additively reduce wild bees in crop fieldsAnina Knauer, Subodh Adhikari, Georg K S Andersson, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Antiviral Therapy|April 6, 2013
Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final resultsStefan Zeuzem, Tarik Asselah, Peter Angus, et al.
Journal of Hepatology|July 30, 2010
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsEric J Gowans, Stuart Roberts, Kathryn Jones, et al.
The New England Journal of Medicine|June 24, 2011
Telaprevir for retreatment of HCV infectionStefan Zeuzem, Pietro Andreone, Stanislas Pol, et al.
Hepatology International|August 25, 2022
Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort studyKurvi Patwala, David Stephen Prince, Yael Celermajer, et al.
Journal of Viral Hepatitis|May 18, 2026
Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry StudyYusuf Yilmaz, Ming-Lung Yu, Khalid Alswat, et al.
Scientific Reports|November 7, 2022
A large-scale dataset reveals taxonomic and functional specificities of wild bee communities in urban habitats of Western EuropeArthur Fauviau, Mathilde Baude, Nicolas Bazin, et al.
Hepatology International|March 3, 2026
Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statementEric Kalo, Jacinta Holmes, Purnima Bhat, et al.
Nature Ecology & Evolution|December 10, 2025
Pesticides and habitat loss additively reduce wild bees in crop fieldsAnina Knauer, Subodh Adhikari, Georg K S Andersson, et al.
Pageof 7